This AI-Designed “Universal Vaccine” Could Stop Future Pandemics Before They Start
The vaccine was well-tolerated in 39 volunteers and triggered immune responses to SARS-CoV-2, SARS and related bat viruses, researchers said.
- Researchers successfully completed the first human trial of a universal coronavirus vaccine, which proved well-tolerated across four doses among 39 volunteers. The vaccine triggered immune responses against SARS-CoV-2, SARS, and related bat viruses.
- Developed via computer simulations, the vaccine utilizes an AI-created protein to target shared features across multiple coronaviruses. Study lead Jonathan Heeney of the University of Cambridge described the old system as a "dog chasing its tail."
- Administered through a microfluidic jet, the vaccine "uses a high-pressure, hair-thin stream of liquid to push vaccine blueprints directly into skin cells," Sky News reported. This needle-free delivery enhances global applicability by reducing volume requirements and eliminating sharps waste.
- This "new class of universal vaccines are future-proofed," protecting against emerging variants and related viruses not yet identified. Saul Faust, professor at the University of Southampton, noted that evolving viruses can render standard vaccines poorly matched by rollout.
- A larger Phase 2 trial will next assess the vaccine's ability to induce immune responses in a wider, more diverse population. Though initial responses were limited, researchers attribute this to prior vaccination history among participants.
17 Articles
17 Articles
This AI-Designed “Universal Vaccine” Could Stop Future Pandemics Before They Start
A groundbreaking AI-designed vaccine aims to protect against not only today’s coronaviruses, but tomorrow’s as well. A new type of universal coronavirus vaccine has passed its first test in humans, marking an important step toward broader protection against future viral threats. Researchers from the University of Cambridge and biotechnology company DIOSynVax (DVX) Ltd reported that [...]
AI VACCINES: THE EPIC FAIL
Media headlines are celebrating an AI-designed “universal vaccine” that Cambridge University researchers suggest could change the future of pandemic response. Jefferey looks past the hype to examine what the study actually shows, and what the headlines leave out. AIRDATE: June 11, 2026
A newly developed universal vaccine could keep pandemics at bay
A needle-free universal vaccine may soon be on the horizon. Scientists have successfully run the first trial, which showed the vaccine can safely elicit an immune response to several viruses. But more research has to be conducted before it’s approved for widespread use.How was the vaccine developed?This universal vaccine is the first human-tested inoculation to have its active component designed by computer simulations, according to a study publ…
The expert believes that all means should be used in vaccine research, but artificial intelligence is not a shortcut to quick results.
British scientists have tested a universal coronavirus vaccine designed from an artificial limb on humans for the first time. Although the preparation proved safe, it was difficult to assess the protective effect of the vaccine because many participants had already recovered from the disease before receiving a full course or had received a more conventional protective injection.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
